<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Sun, 26 May 2013 01:16:47 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>&lt;b&gt;Agea Medical&lt;/b&gt; Has Its Sights on an $8 Million Offering  </title><link>http://www.massdevice.com/news/agea-medical-has-its-sights-8-million-offering</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Agea Medical is $2 million shy of its $8 million funding round goal. Officials at Agea Medical said it is closing in on an $8 million funding round. The Redwood City, Calif.-based medical device company has...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Advanced Accelerator Applications (AAA)&lt;/b&gt; Raises $6.1 Million Capital Increase  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297690&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Advanced Accelerator Applications (AAA) announces completion of 4.8 million capital increase&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;May 23, 2013 (Saint-Genis-Pouilly, France): Advanced Accelerator Applications...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Thermedical Secures $5.5 Million in Series A2 Financing Round  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296818&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;WALTHAM, MA--(Marketwired - May       15, 2013) -   &lt;a href"http://www.thermedical.com/"&gt;Thermedical&amp;#174;&lt;/a&gt;, a medical equipment company developing new tissue-ablation therapies...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Medical Device Developer Raises Nearly $6 Million Funding  </title><link>http://www.bizjournals.com/sanjose/news/2013/04/26/medical-device-developer-nasoform.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Nasoform, a startup that is developing a minimally invasive device to treat collapsed nasal valves, disclosed on Friday that it raised nearly $6 million in venture funding. The Menlo Park company led by Dr...</description><pubDate>Thu, 09 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Channel Medsystems&lt;/b&gt; Gets $9.7 Million, Names &lt;b&gt;Ric Cote&lt;/b&gt; as CEO  </title><link>http://www.bizjournals.com/sanjose/news/2013/05/06/channel-medsystems-gets-97m-names.html?ana=otj</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Channel Medsystems Inc. named Ric Cote as president and CEO and raised $9.7 million in Series B financing. The round was led by Boston Scientific Corp. and included the backing of InCube Ventures, Aperture Ventures...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;STAT-Diagnostica&lt;/b&gt; Raises $22.1 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295358&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;BARCELONA--(BUSINESS WIRE)-- STAT-Diagnostica has announced the closing of a Series B financing round totaling 22.1 million USD/17 million Euros, the proceeds of which will be used to complete development...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>MedPharm Ltd Invests $.75 Million in New Topical Formulation Performance Testing Laboratory  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295476&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Guildford UK, May 6, 2013, In response to strong QI growth in demand for its highly specialised skin permeation / penetration and in vitro release testing (IVRT) services for topical formulations, MedPharm...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Natera&lt;/b&gt; Raises $54.6M for Prenatal Genetic Tests  </title><link>http://www.biospace.com/news_story.aspx?StoryID=294944&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;SAN CARLOS, Calif.--(BUSINESS WIRE)-- Natera today announced that it has completed a $54.6 million financing round to support the expansion and continued global rollout of Nateras non-invasive prenatal...</description><pubDate>Wed, 01 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Cervel Neurotech&amp;#0153;&lt;/b&gt; Announces $14.1 Million Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293909&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;source"news-signup""&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;FOSTER CITY, CA--(Marketwired - April     22, 2013) -   Cervel Neurotech, Inc. a privately held company developing a novel, non-invasive and non-pharmacologic therapy for depression...</description><pubDate>Mon, 22 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Life Image&lt;/b&gt; Raises $35.6 Million  </title><link>http://www.massdevice.com/news/medtech-funding-life-image-raises-356-million</link><description>Medical device company Life Image has raised $35.6 million, according to regulatory filings. Life Image Inc. reported raising $35.6 million in a April 18, 2013, regulatory filing.</description><pubDate>Fri, 19 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Watermark Medical Raises $32.2 Million  </title><link>http://medcitynews.com/2013/04/at-home-testing-for-sleep-apnea-draws-32-2m-from-investors-in-florida-device-company/</link><description>A medical device company hoping to move sleep apnea testing out of expensive and uncomfortable labs and into the realm of primary care has gotten a boost from at least 20 investors. Watermark Medical Inc., which recently merged with sleep diagnostics provider SleepMed, has raised $32.2 million since March, according to a SEC filing. An email to the company was not returned. The company manufactures...</description><pubDate>Fri, 19 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;DySIS Medical&lt;/b&gt; Receives $11.3 Million of Additional Funding  </title><link>http://www.biospace.com/news_story.aspx?StoryID=293227&amp;full=1</link><description>EDINBURGH, Scotland--(BUSINESS WIRE)--DySIS Medical Ltd, a medical devices company active within womens health, today announces the completion of a 7.4 million (gross) fundraising.&lt;/p&gt;&lt;p&gt;    DySIS Medicals technology offers substantial clinical benefits in the fight against cervical cancer as well as improved cost-effectiveness over existing care. We believe DySIS is a compelling business to...</description><pubDate>Mon, 15 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Amendia Inc. Invests $50 Million in Implant Spinoff  </title><link>http://www.bizjournals.com/atlanta/print-edition/2013/04/12/amendia-invests-50m-in-implant-spinoff.html</link><description>Specialty medical-device manufacturer Amendia Inc. will invest up to $50 million to commercialize a biomedical spinoff that focuses on implant technology and stem cell therapies. The new venture, Vivex Biomedical Inc., is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage...</description><pubDate>Fri, 12 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Theradiag Granted 1.2 Million Euros by as Part of the Collaborative Project CaReNA  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292859&amp;full=1</link><description>Croissy-Beaubourg, April 9 2013 - Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has been granted financial support by Oso, the French Agency for Innovation, for its participation in CaReNA. Total development costs for the entire project could reach 18 M. CaReNA is a collaborative project between Splicos, alternative...</description><pubDate>Mon, 08 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Renovis Surgical&lt;/b&gt; Closes $3.5 Million Equity Round  </title><link>https://www.massdevice.com/news/renovis-surgical-closes-35-million-equity-round</link><description>Orthopedic medical device maker Renovis Surgical lands $3.5 million in equity financing. Medical device company Renovis Surgical Technologies closed a $3.5 million funding round through sales of equity financing, according to an SEC filing. The Redlands, Calif.-based company raised the funds from 15 investors, 4 of which did not qualify as accredited investors, but none of which were named in the filing...</description><pubDate>Thu, 04 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>Artery Treatment Startup AtheroMed, Inc. Raises $6 Million  </title><link>http://www.bizjournals.com/sanjose/news/2013/04/04/artery-treatment-startup-atheromed.html?ana=otj</link><description>Artery disease treatment startup AtheroMed Inc. disclosed on Thursday that it raised about $6 million. The Menlo Park-based company led by President Michael MacKinnon didn't disclose specifically who the money came from but said there were 19 investors involved.</description><pubDate>Thu, 04 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Hurel&lt;/b&gt; Receives $9.2 Million Series A Funding  </title><link>http://www.biospace.com/news_story.aspx?StoryID=292248&amp;full=1</link><description>BRUNSWICK, N.J.&lt;/span&gt;, &lt;span class"xn-chron"&gt;April 3, 2013&lt;/span&gt; /PRNewswire/ -- Hurel Corporation ("Hurel"), a world-leading provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms that improve the predictive reliability and over-all efficiency of pre-clinical drug development, today announced that Spring Mountain Capital has organized and closed a &lt;span class...</description><pubDate>Wed, 03 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>EndoStim Funding Round Reaches $11 Million  </title><link>http://www.bizjournals.com/stlouis/blog/BizNext/2013/03/endostim-funding-round-reaches-11.html?ana=otj</link><description>Medical device startup EndoStim has raised $11.2 million of a planned $16.5 million fundraising round, according to an amended filing with the Securities and Exchange Commission. The new filing shows that EndoStim, run by President and Chief Executive Bevill Hogg, now has attracted 67 investors in the funding round, which started Dec. 5. The last time the company filed information about its fundraising...</description><pubDate>Wed, 27 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>University of Missouri Engineering Faculty's Firm Gets $6 Million From Chinese Investors  </title><link>http://www.bizjournals.com/kansascity/blog/morning_call/2013/03/chinese-investors-boost-university-of.html?ana=otj</link><description>Nanova Inc., a high-tech biomaterials firm launched by engineering faculty at the University of Missouri, will get a $6 million boost from Chinese investors, the Missourian reports. The $6 million boost will go toward marketing the firm's medical innovations. MU and Columbia officials are partnering with China-based Summitview Capital in a venture aimed at fostering economic growth for both regions...</description><pubDate>Wed, 27 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>SynapDx Corporation Secures Investment From  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130327005291&amp;newsLang=en</link><description>LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation today announced it has secured a significant investment from The Kraft Group. The funding will support the ongoing clinical development of SynapDxs breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today. Conducting business in more than 90 countries...</description><pubDate>Wed, 27 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>StartX Genome Device Maker Raises $8.5 Million  </title><link>http://www.bizjournals.com/sanjose/news/2013/03/22/startx-genome-startup-genapsys-raises.html?ana=otj</link><description>Genapsys, a company that grew out of Stanford's StartX program, said on Friday it has raised about $8.5 million in a funding round in which it hopes to get about $13.5 million. The Redwood City company is led by founder Hesaam Esfandyarpour and says that its system-on-a-chip genetic sequencing technology can sequence an entire human genome in less than a day for about $30. Its $3,000 device replaces...</description><pubDate>Mon, 25 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Minimally Invasive Devices&lt;/b&gt; Raises $9 Million in Series B Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291392&amp;full=1</link><description>COLUMBUS, Ohio&lt;/span&gt;, &lt;span class"xn-chron"&gt;March 25, 2013&lt;/span&gt; /PRNewswire/ -- Minimally Invasive Devices, Inc. (MID), today announced it has completed a &lt;span class"xn-money"&gt;$9 million&lt;/span&gt; Series B financing led by Canaan Partners. Charter Life Science, an existing investor, also participated in the financing. Coinciding with the close of the Series B, &lt;span class"xn-person"&gt;Brent Ahrens...</description><pubDate>Mon, 25 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Medrobotics&lt;/b&gt; Closes on $10 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=291308&amp;full=1</link><description>RAYNHAM, Mass.--(BUSINESS WIRE)-- Medrobotics Corporation, an emerging medical robotics company developing the innovative Flex Robotic System, announced the recent closing of up to $10 Million in new debt financing from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital, Inc. The financing precedes Medrobotics anticipated commercial launches in Europe and the United...</description><pubDate>Fri, 22 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Topera Medical Raises $25 Million  </title><link>http://www.massdevice.com/news/funding-topera-medical-raises-25-million</link><description>San Diego, Calif.-based start-up Topera Medical closes a $25 million funding round for its RhythmView 3D mapping system for arrhythmia. Medical device start-up Topera Medical closed a $25 million funding round, according to federal Securities &amp; Exchange Commission filings. The San Diego, Calif.-based startup, which came out of stealth mode at the Heart Rhythm Society meeting last year, has FDA 51...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Investors Pump $9 Million Into Heart Device Biz,  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290906&amp;full=1</link><description>Tewksbury, Mass.  DC DevicesInc., an innovative medical device company developing first-in-class structural heart devices, today announced that it has secured $9 million in financing. Lumira Capital joined the financing along with the company's existing investors Third Rock Ventures and General Catalyst, and Gerry Brunk, managing director of LumiraCapital, has joined the DC Devices board of directors...</description><pubDate>Tue, 19 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;EyeTechCare&lt;/b&gt; Raises $13 Million in Third Round  </title><link /><description>Rillieux-la-Pape, France, March 12, 2013 - French company EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that it has secured a third round of funding amounting to EUR ten million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors who...</description><pubDate>Wed, 13 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>Medical Device Startup nContact, Inc. Raises $6.7 Million, Wants Another $6 Million  </title><link>http://www.bizjournals.com/triangle/news/2013/03/08/morrisvilles-ncontact-in-13m.html</link><description>Medical device company nContact, a developer of products to treat arrhythmias or disorders of the heart rate, is halfway through raising a new venture capital financing round of $13 million. According to an SEC filing made Friday, nContact said it had raised $6.74 million from 10 different investors. The company wants to raise a total of $13 million. In January 2012, nContact raised close to half a...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Credentis ag&lt;/b&gt; Announces Successful Closing of B-Round Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=290120&amp;full=1</link><description>March 11, 2013 -- Credentis ag announces a first closing of its B-round financing. Investments currently amounting to a minimum of 1.59 Mio CHF were made solely by management and existing investors including cantonal banks ZKB and AKB, StartAngels Network, BioBAC Angels, and a number of private investors including known dentists and exponents of the dental industry. The new capital will allow...</description><pubDate>Mon, 11 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Basis&lt;/b&gt; Raises $11.5 Million for Health-Tracking Wristwatch  </title><link>http://www.biospace.com/news_story.aspx?StoryID=289614&amp;full=1</link><description>March 06, 2013 -- BASIS Science Inc., a San Francisco-based startup developing a wrist-based health tracker and online platform, has raised $11.5 million in Series B funding. The round was led by Mayfield Fund, with investment from existing investors DCM and Norwest Venture Partners. Tim Chang, Managing Director at Mayfield, joins Basis board of directors. Basis also bolstered its advisory board with...</description><pubDate>Wed, 06 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Swallow Solutions, LLC&lt;/b&gt; Secures $1.046 Million Series A Financing  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20130301005563&amp;newsLang=en</link><description>MADISON, Wis.--(BUSINESS WIRE)--Swallow Solutions, LLC (Swallow Solutions), a life sciences company with a novel dysphagia treatment platform, announced today it has raised $1.046 million in Series A financing, led by Venture Management, LLC, with participation from NEW Capital Fund, LP, Wisconsin Investment Partners, and individual investors. Swallow Solutions will use the capital to commercialize...</description><pubDate>Fri, 01 Mar 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;SHL&lt;/b&gt; to Invest $40 Million in 2013 to Significantly Expand Production Facilities  </title><link>http://www.biospace.com/news_story.aspx?StoryID=288514&amp;full=1</link><description>Taoyuan, Taiwan (PRWEB) February 25, 2013 -- SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&amp;D. With the rapid growth of the biologic injectable market, device suppliers are under pressure to broaden the range of...</description><pubDate>Mon, 25 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Sapiens&lt;/b&gt; Nabs $9.9 Million to Drive Development of Next Generation Deep Brain Stimulation Therapy
  </title><link>http://www.biospace.com/news_story.aspx?StoryID=288515&amp;full=1</link><description>Munich, Germany, and Eindhoven, the Netherlands, February 25, 2013 - Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical technology company developing brain stimulation products, today announced that it has raised 7.5 m from the Dutch investment group INKEF Capital, in a further extension of their Series A financing round. The proceeds will be used for the development of its Steering...</description><pubDate>Mon, 25 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Avra Surgical Robotics Inc.&lt;/b&gt; Raising $15 Million  </title><link>http://www.bizjournals.com/atlanta/blog/a-healthy-conversation/2013/02/atlanta-doctors-company-raising-15m.html?ana=otj</link><description>A robotic surgery company whose president is a former Atlanta doctor is planning to raise $15 million. The company, Avra Surgical Robotics Inc., today filed with the Securities and Exchange Commission for a stock sale. Avra's president is Dr. Sudhir Srivastava, who launched the International College of Robotic Surgery at Saint Joseph's Hospital in Atlanta in 2009 and served as its president until March...</description><pubDate>Wed, 13 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Innovative Pulmonary Solutions Inc.&lt;/b&gt; Closed on $10 Million  </title><link>http://www.bizjournals.com/twincities/blog/in_private/2013/02/med-tech-startup-moves-hq-to-plymouth.html?ana=otj</link><description>Med-tech startup Innovative Pulmonary Solutions Inc. (IPS) has changed its name, moved its headquarters from Washington state to Plymouth, and closed on $10 million in venture capital. IPS announced last year that it would relocate from Bellevue, Wash., to the Twin Cities, after naming Dennis Wahr, a local serial med-tech entrepreneur, to serve as its CEO. The company said Monday it has changed its...</description><pubDate>Wed, 13 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Qvanteq AG&lt;/b&gt; Closes Series B Financing Round of $4.3 Million to Obtain Clinical Proof of Concept and CE Mark  </title><link>http://www.biospace.com/news_story.aspx?StoryID=287394&amp;full=1</link><description>February 12, 2013 -- The Swiss coronary stent developer Qvanteq AG closes series B financing round of 4 million Swiss Francs to obtain clinical proof of concept and CE mark&lt;/p&gt;&lt;p&gt;Series B financing round&lt;/p&gt;&lt;p&gt;Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to...</description><pubDate>Tue, 12 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Holaira&lt;/b&gt; Closes $10 Million in Series C Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=287250&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;MINNEAPOLIS, MN--(Marketwire - February  11, 2013) -   &lt;b&gt; &lt;/b&gt;&lt;a href"http://ctt.marketwire.com/?release983699&amp;id2593291&amp;type1&amp;urlhttp%3a%2f%2fwww.holaira.com"&gt;Holaira, Inc.&lt;/a&gt;, formerly Innovative Pulmonary Solutions, Inc. (IPS), a developer of medical devices to treat obstructive lung diseases, today announced the completion of its Series C private equity financing...</description><pubDate>Mon, 11 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>Glaukos Corporation Raises $30 Million  </title><link>http://www.ocregister.com/articles/glaukos-494740-device-glaucoma.html</link><description>Glaukos Corp. in Laguna Hills has raised $30 million in equity funding for the U.S. marketing of its implantable device for the treatment of glaucoma. The funding round was led by Meritech Capital Partners and joined by existing investors including Versant Ventures, Domain Associates, Montreux Equity Partners, InterWest Partners, Frazier Healthcare, OrbiMed Advisors and Gund Investment Corp. Glaukos...</description><pubDate>Wed, 06 Feb 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Nanjing Micro-Tech&lt;/b&gt; Announces "Significant" Investment From &lt;b&gt;Actis&lt;/b&gt;  </title><link>http://www.chinabiotoday.com/articles/20130115_1</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;January 15, 2013 -- Nanjing Micro-Tech, a China medical device maker, has received an equity investment from Actis, a private equity company that invests in emerging countries. Without releasing specific details, the company called the capital infusion significant while also disclosing that the equity purchased a minority stake. Founded in 2000, Nanjing Micro-Tech...</description><pubDate>Wed, 16 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;GSI Group&lt;/b&gt; to Acquire NDS Surgical Imaging for $82.5 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284794&amp;full=1</link><description>BEDFORD, Mass.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Jan. 15, 2013&lt;/span&gt; /PRNewswire/ -- GSI Group Inc. (NASDAQ: GSIG) (the "Company" or "GSI"), a leading supplier of laser-based solutions, precision motion and optical technologies to global industrial, medical, electronics, and scientific markets, today announced that it has acquired NDS Surgical Imaging ("NDS"), a &lt;span class"xn-location"&gt;San Jose, California...</description><pubDate>Tue, 15 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Ceterix Orthopaedics&lt;/b&gt; Raises $19.5 Million for Safe Suture Device  </title><link>https://www.massdevice.com/news/ceterix-orthopaedics-raises-195m</link><description>Surgical tools maker Ceterix Orthopaedics raises a $19.5 million funding round. Ceterix Orthopaedics landed $19.5 million from 5 investers, according to a regulatory filing. The Menlo Park, Calif-based surgical tools maker said it plans to raise an additional $1.10 million, Medcity News reported. Ceterix is developing a suturing device designed to help surgeons stitch difficult anatomies while avoiding...</description><pubDate>Tue, 15 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Open Prairie Ventures&lt;/b&gt; Invests $7 Million in KC BioMediX, Inc.  </title><link>http://www.bizjournals.com/kansascity/news/2013/01/14/open-prairie-ventures-invests-7m.html?ana=otj</link><description>Kansas City-based Open Prairie Ventures has invested in a St. Louis agricultural biotech firm in a round of financing totaling $7 million. Open Prairie Ventures, which has offices in Kansas City and Illinois, has two portfolio companies in the area: KC BioMedix Inc. in Shawnee and Novita Therapeutics in Olathe. Open Prairie was among several other companies and individuals to invest in NewLeaf Symbiotics...</description><pubDate>Tue, 15 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PatientSafe Solutions&lt;/b&gt; Closes $20 Million Series C Funding  </title><link /><description>January 15, 2013 -- PatientSafe Solutions, a privately held company, today announced that it has closed a $20 million Series C round of financing led by the Merck Global Health Innovation (GHI) fund and with participation from investors including Camden Partners, TPG Capital, and Psilos Group. PatientSafe also announced that Max Kahn, an investment principal at Merck GHI, has joined PatientSafes Board...</description><pubDate>Tue, 15 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Manchester Receives $12.6 Million Investment  </title><link>http://www.insidermedia.com/insider/north-west/82968-</link><description>North West Evergreen fund has committed 9.5m of investment into Manchester-based biomedical centre Citylabs. The centre is a specialised space that provides laboratories and offices to the biomedical sector, and will be home to NHS spin-outs, providers to the pharmaceutical, biotechnology and medical device industries, as well as The Manchester College and The Central Manchester University Hospitals...</description><pubDate>Fri, 11 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>JumpStart Invests $250,000 in  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284250&amp;full=1</link><description>January 09, 2013 -- Guided Interventions, LLC, a startup company developing a product to help cardiologists better assess the physiological impact of coronary artery blockages, has received a $250,000 investment commitment from nonprofit venture development organization JumpStart Inc. Guided Interventions novel fractional flow reserve (FFR) guidewire provides an easier, more effective and more affordable...</description><pubDate>Tue, 08 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>California Device Startup, Raises $20 Million  </title><link>http://medcitynews.com/2013/01/california-device-start-up-treating-abnormal-uterine-bleeding-raises-20m/</link><description>California device startup and womens health firmMinerva Surgical has recently raised $20 million, according to a regulatory filing. The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treatheavy menstrual bleeding. Based on a search of the U.S. Securities and Exchange Commissions Edgar database, the company has been steadily...</description><pubDate>Fri, 04 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;eZono AG&lt;/b&gt; Closes $10 Million Financing Round  </title><link>http://www.biospace.com/news_story.aspx?StoryID=283486&amp;full=1</link><description>JENA, Germany--(BUSINESS WIRE)-- eZono AG (eZono), a private corporation that develops portable tablet ultrasound systems, announced today that it has completed an equity financing of up to $10m. The capital increase is led by new investor MVM Life Science Partners LLP (MVM). In conjunction with the financing, MVM partner Hugo Harrod will join eZonos board of directors.&lt;/p&gt;&lt;p&gt;In May 2009...</description><pubDate>Thu, 03 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>EndoStim Taps Investors for $8 Million  </title><link>http://www.bizjournals.com/stlouis/print-edition/2012/12/21/endostim-taps-investors-for-8-million.html</link><description>Bevil Hogg is raising money once again. Local medical device startup EndoStim, where Hogg serves as president and CEO, has raised $8.16 million in a total fundraising round of $12 million, according to documents filed with the Securities and Exchange Commission (SEC). The private equity offering, which started Dec. 5, has attracted investments from 41 investors, according to the SEC documents.</description><pubDate>Wed, 26 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Medrobotics&lt;/b&gt; Completes $33.6 Million Series D Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=282904&amp;full=1</link><description>RAYNHAM, Mass.--(BUSINESS WIRE)-- Medrobotics Corp., an emerging medical robotics company developing the innovative Flex Robotic System, announced today the conversion of notes totaling $33.6 Million purchased through recent financings into Series D Preferred Stock. Existing Medrobotics shareholders and undisclosed new investors participated in the Series D raise. Proceeds will be used for regulatory...</description><pubDate>Thu, 20 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PatientSafe Solutions&lt;/b&gt; Raises $13.3 Million  </title><link>http://www.utsandiego.com/news/2012/dec/18/patientsafe-solutions-raises-133-million/</link><description>PatientSafe Solutions has raised $13.3 million in equity financing from private investors, according to a filing Tuesday with the Securities and Exchange Commission. The company is seeking a maximum of $25.7 million, the filing stated, leaving about $12.4 million more that can be raised. Privately held PatientSafe develops health care software and hardware that runs on consumer mobile devices, to improve...</description><pubDate>Wed, 19 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Sharklet Technologies&lt;/b&gt; Closes $2 Million in Series B Financing  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20121211005082&amp;newsLang=en</link><description>AURORA, Colo.--(BUSINESS WIRE)--Sharklet Technologies today announced that it has attracted additional capital from Altria Ventures for accelerated growth and development of Sharklet, the worlds first bacteria-inhibiting micro-texture surface technology. Altria Ventures, the venture capital investment arm of Altria Group, Inc., will invest $2 million in Sharklet Technologies in exchange for a 1...</description><pubDate>Tue, 11 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Biomatrica Secures Financing of $5 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281456&amp;full=1</link><description>SAN DIEGO&lt;/span&gt;, &lt;span class"xn-chron"&gt;Dec. 6, 2012&lt;/span&gt; /PRNewswire/ -- Biomatrica, Inc., a leader in ambient temperature biostability technology, today announced the completion of &lt;span class"xn-money"&gt;$5 million&lt;/span&gt; in private financing. Biomatrica has developed SampleMatrix&lt;sup&gt;&lt;/sup&gt; technology which has pioneered recent innovations in ambient storage of biological samples, from purified...</description><pubDate>Thu, 06 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Ohio Device Startup, Sees National Expansion, $5 Million Fundraise in the Cards for 2013  </title><link>http://medcitynews.com/2012/12/ohio-device-startup-sees-national-expansion-5-million-fundraise-in-the-cards-for-2013/</link><description>When a medical device company is working in the same market space as players like Stryker and Olympus, securing U.S. Food and Drug Administration clearance is only half the battle. Solon, Ohio-based medical device company Thermedx has the FDA clearance in place as well as several local customers and is now embarking on the mission of establishing a presence outside of its home state. Thermedx makes...</description><pubDate>Thu, 06 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Nico&lt;/b&gt; Raises $6.5 Million More From Existing Investors  </title><link>http://www.ibj.com/nico-raises-65-million-more-from-existing-investors/PARAMS/article/38294</link><description>Indianapolis-based Nico Corp. has raised another $6.5 million in venture capital from its existing shareholders and board members, the Indianapolis-based medical device maker announced Monday. Nicos Myriad line of products allow minimally invasive removal of brain tumors and tissue in adults and children. Now Nico wants to use the new round of capital to develop technology to address diseases that...</description><pubDate>Wed, 05 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Seno Medical Instruments, Inc. Raises $15 Million  </title><link>http://www.massdevice.com/news/seno-medical-instruments-raises-15m</link><description>Seno Medical Instruments raises nearly $15 million of a hoped-for $21 million for its opto-acoustic imaging technology for detecting cancer. Seno Medical Technologies raised $14.5 million in an equity round from 28 unnamed investors, according to a regulatory filing. The San Antonio, Texas-based medical device company is developing opto-acoustic imaging technology to locate cancerous tumors in breast...</description><pubDate>Thu, 15 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Sanovas&lt;/b&gt; Seeks $25 Million as it Gears Up to Go Commercial  </title><link>https://www.massdevice.com/features/sanovas-seeks-25-million-it-gears-go-commercial</link><description>Medical device company Sanovas is looking to raise about $25 million to commercialize its next-generation Vas Zeppelin pulmonary device designed to scan, diagnose and treat lung disease in a single sitting. Sanovas gears up to go commercial. Medical device company Sanovas is looking to raise about $25 million to commercialize its next-generation pulmonary device designed to scan, diagnose and treat...</description><pubDate>Wed, 14 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Epic Sciences&lt;/b&gt; Gets $13 Million for Cancer Diagnostics  </title><link>http://www.biospace.com/news_story.aspx?StoryID=279535&amp;full=1</link><description>SAN DIEGO--(BUSINESS WIRE)-- Epic Sciences, Inc. (Epic), a private biotech company that develops breakthrough cancer diagnostics, announced today that it has completed a $13 million Series B equity financing. This financing includes new investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, in addition to undisclosed individual investors. In conjunction with the financing...</description><pubDate>Tue, 13 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Oxford Finance&lt;/b&gt; Provides $17 Million Debt Financing Facility to Entellus Medical  </title><link>http://www.biospace.com/news_story.aspx?StoryID=277025&amp;full=1</link><description>ALEXANDRIA, Va., Oct. 23, 2012 -- /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $17 million senior secured term loan with Entellus Medical. Proceeds of the loan are being used to support the company's ongoing commercialization of its therapeutic solutions for healthcare...</description><pubDate>Wed, 24 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Weight Loss: ReShape Medical Forms Up $16 Million  </title><link>http://www.massdevice.com/news/weight-loss-reshape-medical-form-16m-wall-street-beat</link><description>ReShape Medical raises $16 million in an equity round it hopes will wind up adding $22 million to its coffers for its dual-intragastric weight loss balloon. ReShape Medical reeled in $15.8 million of a hoped-for $21.5 million funding round from a group of 7 unnamed investors, according to a regulatory filing. The San Clemente, Calif.-based medical device company is developing a non-surgical weight...</description><pubDate>Tue, 23 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Spinal Restoration, Inc. Closes $5 Million Round for FDA Submission  </title><link>http://www.biospace.com/news_story.aspx?StoryID=276869&amp;full=1</link><description>AUSTIN, Texas--(BUSINESS WIRE)-- Spinal Restoration, Inc. announced today the closing of a $5 million financing round that will fund the companys Biologic License Application (BLA) submission and early commercialization efforts for the Biostat System. The $5 million in financing includes $3 million in equity from current investors Austin Ventures, Sante Ventures, and MB Venture Partners, and a ...</description><pubDate>Tue, 23 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Imaging Agent Maker Raises $11 Million  </title><link>https://www.massdevice.com/news/imaging-agent-maker-shine-medical-raises-11m-wall-street-beat</link><description>Shine Medical raises $11 million for its alternative, non-nuclear method of creating imaging agents. Shine Medical closed an $11.4 million funding round for its method of generating a low-energy neutron source for medical imaging that uses a particle accelerator instead of a nuclear reactor. The Monona, Wis.-based company is aiming to provide an alternative to molybdenum-99, which has become an uncertain...</description><pubDate>Mon, 22 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Ardian Co-Founders Launch With $10 Million to Tweak "Fight-or-Flight"  </title><link>http://www.biospace.com/news_story.aspx?StoryID=276303&amp;full=1</link><description>NEW YORK CITY  October 17, 2012  Cibiem, Inc. today announced the successful completion of a $10 million Series A round led by top-tier life sciences venture investors SV Life Sciences and Third Rock Ventures. The company is launching out of Coridea, a premier medical device incubator focused on innovation driven by new targets in the cardio-renal and cardio-pulmonary fields. Proceeds from the financing...</description><pubDate>Wed, 17 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Mainstay Medical&lt;/b&gt; Raises $20 Million in Funding Round  </title><link>http://www.biospace.com/news_story.aspx?StoryID=274131&amp;full=1</link><description>Dublin, Ireland, 26th September, 2012  Medical device company Mainstay Medical Ltd. today announced that is has successfully completed an oversubscribed Series B financing round for $20.0M (15.3M) led by Fountain Healthcare Partners (Ireland - Fountain). Other new investors in the Series B round include Medtronic (US - Medtronic), Capricorn Venture Partners (Belgium - Capricorn) and Seventure...</description><pubDate>Wed, 26 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Aviir Diagnostic Laboratories&lt;/b&gt; Secures $8 Million in Funding From Silicon Valley Bank  </title><link>http://www.biospace.com/news_story.aspx?StoryID=273675&amp;full=1</link><description>IRVINE, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Sept. 19, 2012&lt;/span&gt; /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced today that it has secured &lt;span class"xn-money"&gt;$5 million&lt;/span&gt; in growth debt capital and a &lt;span class"xn-money"&gt;$3 million&lt;/span&gt; line of credit on receivables from Silicon...</description><pubDate>Thu, 20 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Healthsense&lt;/b&gt; Gets $7 Million in Funding From Merck &amp; Co., Inc., Others  </title><link>http://www.bizjournals.com/twincities/news/2012/09/19/healthsense-gets-funding-from-merck.html?ana=otj</link><description>Minneapolis / St. Paul Business Journal by Ed Stych, Web Producer &lt;/p&gt;&lt;p&gt;Healthsense Inc., a Twin Cities company that markets health-monitoring systems for seniors, said Wednesday it has received $7 million in financing from Merck Global Health Innovation Fund and others.&lt;/p&gt;&lt;p&gt;Mendota Heights-based Healthsense said in a news release that Fallon Community Health Plan was another one of the...</description><pubDate>Thu, 20 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Medical Device Startup,  Raises $5.3 Million to Reduce Radiation in Medical Procedures  </title><link>http://medcitynews.com/2012/09/medical-device-startup-raises-5-3-million-to-reduce-radiation-in-medical-procedures/</link><description>Company name: IntelliRad Control. Location: Radnor, Pennsylvania. Industry: medical device with applications for cardiology, orthopedics, etc. Money raised: $5.3 million, according to documents filed with the U.S. Securities and Exchange Commission. A device to dramatically reduce the dose of radiation used in diagnostic and therapeutic procedures without changing the physician-patient experience...</description><pubDate>Wed, 19 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>BioFire Diagnostics, Inc Secures $25 Million Financing From  </title><link>http://www.biospace.com/news_story.aspx?StoryID=273238&amp;full=1</link><description>SALT LAKE CITY, Sept. 18, 2012 (GLOBE NEWSWIRE) -- BioFire Diagnostics, Inc. today announced its completion of a $25 million financing with Athyrium Opportunities Fund. The proceeds from the financing will be used to accelerate the commercialization of the Company's FilmArray diagnostic platform. Proceeds will also be used to further develop additional panels beyond the FDA-cleared, CE IVD marked...</description><pubDate>Tue, 18 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Provista Diagnostics (PDx) Announces the Closing of Additional $2.5 Million Series A Preferred Financing  </title><link>http://www.globenewswire.com/newsroom/news.html?d=10005421v</link><description>Scottsdale, Arizona, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a provider of oncology-based diagnostic tests and clinical laboratory services to the pharmaceutical and biotechnology industries, today announced that it has sold an additional $2.5 million of Series A preferred stock to qualified institutional and individual investors.  This closing brings the total amount raised...</description><pubDate>Tue, 18 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Conventus&lt;/b&gt; Lands $4.5 Million in Capital  </title><link>http://www.bizjournals.com/twincities/print-edition/2012/09/14/conventus-lands-45m-in-capital.html?ana=otjrss</link><description>Minneapolis / St. Paul Business Journal by Katharine Grayson, Staff reporter &lt;/p&gt;&lt;p&gt;Med-tech firm Conventus Orthopaedics Inc. has closed on $4.5 million in financing, according to a regulatory filing.&lt;/p&gt;&lt;p&gt;The Maple Grove-based company developed a device, called the Conventus DRS implant, that treats wrist fractures. A surgeon inserts the device through a small incision in the arm. The product...</description><pubDate>Fri, 14 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Intact Vascular Reels in $11 Million  </title><link>http://www.bizjournals.com/philadelphia/news/2012/08/30/intact-vascular-reels-in-11m.html?ana=otj</link><description>Philadelphia Business Journal by Peter Key, Reporter &lt;/p&gt;&lt;p&gt;Intact Vascular Inc. has raised $11.2 million in a private-equity sale, according to a filing the Wayne, Pa., company made with the Securities and Exchange Commission on Thursday.&lt;/p&gt;&lt;p&gt;Intact Vascular filed to sell $18.8 million, so it can still raise $7.6 million from the round, according to the filing, which was provided to the...</description><pubDate>Fri, 31 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;CompanDX&lt;/b&gt;, a UK Biomarker Startup, Raises $6.1 Million From China  </title><link>http://www.chinabiotoday.com/articles/20120829</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;August 28, 2012 -- CompanDX, a UK diagnostic startup, raised $6.1 million (39.6 million RMB) from China sources, the money coming from a combination of government and private investors. The company has developed bioinformatics algorithms to identify the group of patients that will respond to a particular therapy. The investment makes the China investors eligible to...</description><pubDate>Wed, 29 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Sophono Secures $7 Million in New Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=271046&amp;full=1</link><description>Boulder, Colo. (PRWEB) August 27, 2012 -- Sophono, Inc., the medical device manufacturer specializing in implantable, bone conduction hearing devices, has closed on $7 million in growth capital financing. &lt;/p&gt;&lt;p&gt;Wexford Capital LP led the Series B round of financing. Based in Greenwich, Conn., Wexford is an SEC-registered investment advisor with more than $5.1 billion of assets under management...</description><pubDate>Mon, 27 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Telcare Raises $25.5 Million in Financing, Led by Sequoia Capital  </title><link>http://www.telecompaper.com/news/telcare-secures-usd-255-mln-in-funding</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;BETHESDA, MD--(Marketwire - August    21, 2012) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href"http://www2.marketwire.com/mw/mmframe?prid922141&amp;attachid2072343"&gt;Telcare&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; Telcare, Inc., developer of the first FDA-cleared wireless glucose monitoring system for people with diabetes...</description><pubDate>Wed, 22 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>California Medical Device Startup, Rox Medical Inc. Ttreating COPD Raises $5 Million in Search of $9 Milllion  </title><link>http://medcitynews.com/2012/08/california-medical-device-startup-treating-copd-raises-5m-in-search-of-9m/?edition=medical-devices</link><description>Solution/Product: Anastomotic Coupler System, an implanted device delivered via a catheter for patients with severe chronic pulmonary disease. Money Raised: $5.4 million, looking to raise a total of $9.04 million; company has raised $53.1 million, excluding this round, since 2004. How it will be used:A call to CEO Rodney Brenneman wasnt immediately returned</description><pubDate>Mon, 20 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Retia Medical Raises $7 Million to Develop Accurate, Less-Invasive Cardiovascular Monitor  </title><link>http://www.biospace.com/news_story.aspx?StoryID=270292&amp;full=1</link><description>East Lansing, MI - August 16, 2012  Retia Medical, a medical device company pioneering the field of cardiovascular signal processing for patient monitoring, announced it had raised $7 Million in Series A funding. The Pritzker/Vlock family office led the investment in Retia, which was co-founded by Rama Mukkamala, Associate Professor of Electrical and Computer Engineering at Michigan State University...</description><pubDate>Thu, 16 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Cardia Access Inc.&lt;/b&gt; Seeks $5.4 Million  </title><link>http://medcitynews.com/2012/08/fundraising-pacing-and-icd-lead-design-company-seeks-5-4-million/?edition=medical-devices</link><description>Company name: Cardia Access Inc. Industry: Medical Device. Location: Eden Prairie, Minnesota. Solution/product: Developing lead conductor technology that is patent protected, according to Twin Cities Angel website. Company has no website. Money raised: $160,000 out of a total of $5.4 million sought. How it will be used: Unknown; Chairman and CEO John Erb did not immediately respond to a request for...</description><pubDate>Tue, 14 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Solegear Bioplastics Inc. Completes Series A Financing Led by  </title><link>http://www.biospace.com/news_story.aspx?StoryID=269548&amp;full=1</link><description>VANCOUVER, BRITISH COLUMBIA--(Marketwire -08/09/12)- Solegear Bioplastics Inc., a developer of award-winning bioplastic technologies, today announced it has secured Series A financing, led by Yaletown Venture Partners and joined by a number of leading angel investors.&lt;/p&gt;&lt;p&gt;"The completion of this major financing milestone is yet another important step toward Solegear's goal of being a leader in...</description><pubDate>Thu, 09 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Ares Capital&lt;/b&gt; Leads $6 Million Credit Facility for &lt;b&gt;Respicardia&lt;/b&gt;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=269042&amp;full=1</link><description>NEW YORK, Aug 06, 2012 (BUSINESS WIRE) -- Ares Capital Corporation announced today that it closed its first venture finance transaction with Respicardia(R), Inc., an early stage company developing a medical device targeted to improve respiratory and cardiovascular health by treating central sleep apnea. Ares Capital served as lead agent in a $6 million senior secured credit facility to provide working...</description><pubDate>Mon, 06 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>ExoStat Medical Seeks $4 Million  </title><link>http://medcitynews.com/2012/08/fundraising-startup-that-makes-co2-monitoring-tool-to-detect-septic-shock-seeks-4-million/?edition=medical-devices</link><description>Company name: ExoStat Medical Inc. Industry: Medical Devices. Location: Prior Lake, Minnesota. Solution/product: MicroStat is a hand-held system that measures CO2 levels under the tongue to diagnose septic shock. Money raised: $565,000; seeking $4 millionin total. How it will be used: A call to company was not immediately returned. Investors: Unknown; shares were distributed among chairman and two...</description><pubDate>Mon, 06 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Cleveland Heart Raises $30 Million  </title><link>http://www.bizjournals.com/charlotte/print-edition/2012/08/03/group-pumps-30-million-into-cleveland.html?ana=otjrss</link><description>Charlotte Business Journal by Jennifer Thomas, Staff Writer&lt;/p&gt;&lt;p&gt;Cleveland Heart Inc. has received a $30 million investment that will aid efforts to bring its version of the total artificial heart to market.&lt;/p&gt;&lt;p&gt;That medical-device company is a joint venture between Charlotte-based Trans-?World Medical Devices and Cleveland Clinic Foundation, the corporate venture arm of the Cleveland Clinic...</description><pubDate>Fri, 03 Aug 2012 12:00:00 AM GMT</pubDate></item><item><title>Altura Medical Raises $6 Million  </title><link>http://medcitynews.com/2012/07/fundraising-abdominal-aortic-aneurysm-repair-company-raises-6-million/?edition=medical-devices</link><description>Product:Abdominal Aortic Aneurysm Stent-Graft to repair abdominal aortic aneurysms. Money raised: $6 million (earlier regulatory filings show the company raised an additional $16.5 million). How it will be used: To fund ongoing product development and clinical trials that will help toward obtaining CE Mark for commercalization in Europe.</description><pubDate>Thu, 26 Jul 2012 12:00:00 AM GMT</pubDate></item></channel></rss>